(Q44754181)

6 December 2017

Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT. (English)

1 reference

6 December 2017

3

1 reference

6 December 2017

4

N A Athanasou

1 reference

6 December 2017

F Hemingway

1

1 reference

PubMed ID

23391709

6 December 2017

T G Kashima

series ordinal

2

1 reference

6 December 2017

4 February 2013

1 reference

Experimental and Molecular Pathology

6 December 2017

1 reference

6 December 2017

94

1 reference

6 December 2017

2

1 reference

6 December 2017

380-385

1 reference

Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

The molecular understanding of osteoclast differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

The osteoclast--what's new?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Osteoclast differentiation and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

LIGHT-HVEM signaling and the regulation of T cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

NADPH oxidase activation is required for migration by LIGHT in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Tumor necrosis factor alpha-induced osteoclastogenesis requires tumor necrosis factor receptor-associated factor 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

TRAF5 functions in both RANKL- and TNFalpha-induced osteoclastogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

LIGHT up-regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Akt1 in osteoblasts and osteoclasts controls bone remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Lymphotoxin and LIGHT signaling pathways and target genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Signal transduction pathways regulating osteoclast differentiation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

RANKL-RANK signaling in osteoclastogenesis and bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2013.01.003

10.1016/J.YEXMP.2013.01.003

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference

PubMed ID

23391709